NAUT News and Press, Nautilus Biotechnology Inc.

2024-07-30 15:16:09 ET Nautilus Biotechnology, Inc. (NAUT) Q2 2024 Earnings Conference Call July 30, 2024 08:30 ET Company Participants Ji-Yon Yi - Investor Relations Sujal Patel - Co-Founder & Chief Executive Officer Parag Mallick - Co-Founder & Chief Sc...

2024-07-30 08:19:29 ET More on Nautilus Biotechnology Seeking Alpha’s Quant Rating on Nautilus Biotechnology Historical earnings data for Nautilus Biotechnology Financial information for Nautilus Biotechnology Read the full article on Seeking Alpha ...

SEATTLE, July 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the second quarter ended June 30, 2024. “In Q2, we saw con...

2024-07-29 12:34:07 ET More on Nautilus Biotechnology Nautilus Biotechnology, Inc. (NAUT) Q1 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on Nautilus Biotechnology Historical earnings data for Nautilus Biotechnology Financial information ...

SEATTLE, July 09, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein analysis platform, today announced it will report financial results for the second quarter 2024 before market open on Tuesday, July 3...

SEATTLE, May 23, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the Goldman Sachs 45th Annual Healthcare Conference. Nauti...

2024-04-30 13:19:08 ET Nautilus Biotechnology, Inc. (NAUT) Q1 2024 Earnings Conference Call April 30, 2024 08:30 AM ET Company Participants Sujal Patel - Co-Founder & Chief Executive Officer Parag Mallick - Co-Founder & Chief Scientist Anna Mowry - Chief ...

2024-04-30 08:04:42 ET More on Nautilus Biotechnology Nautilus Biotechnology, Inc. (NAUT) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Nautilus Biotechnology Historical earnings data for Nautilus Biotechnology Financial information ...

SEATTLE, April 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial results for the first quarter ended March 31, 2024. “We continued to ...

LPL Financial Holdings Inc. (LPLA) is expected to report $3.77 for Q1 2024 Banco Santander Brasil SA American Depositary Shares each representing one unit (BSBR) is expected to report $0.14 for Q1 2023 EnLink Midstream LLC representing Limited Partner Interests (ENLC) is expected to repor...